Search

Author/Creator Girard, Jean-Marc

1. Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial. Issue 7 (July 2022)

Authors:
Foley, John F; Defer, Gilles; Ryerson, Lana Zhovtis; Cohen, Jeffrey A; Arnold, Douglas L; Butzkueven, Helmut; Cutter, Gary; Giovannoni, Gavin; Killestein, Joep; Wiendl, Heinz; Smirnakis, Karen; Xiao, Shan; Kong, George; Kuhelj, Robert; Campbell, Nolan; van der Walt, Anneke; Dwyer, Christopher; Bu...
Journal:
Lancet neurology
Issue:
Volume 21:Issue 7(2022)
Page Start:
608
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Pulsed chemical vapor deposition of conformal GeSe for application as an OTS selector. Issue 5 (3rd February 2021)

Authors:
Haider, Ali; Deng, Shaoren; Devulder, Wouter; Maes, Jan Willem; Girard, Jean-Marc; Khalil El Hajjam, Gabriel; Kar, Gouri Sankar; Opsomer, Karl; Detavernier, Christophe; Givens, Michael; Goux, Ludovic; Van Elshocht, Sven; Delhougne, Romain; Delabie, Annelies; Caymax, Matty; Swerts, Johan
Journal:
Materials advances
Issue:
Volume 2:Issue 5(2021)
Page Start:
1635
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search